Thursday, 03 May 2012
The chairman of the US Federal Trade Commission (FTC) said today that the 11th Circuit Court of Appeals’ decision in the Phoebe Putney/Palmyra merger case was “disturbingly, jarringly wrong,” and that he expects the Supreme Court to hear the commission’s appeal. Ron Knox in Arlington
Friday, 09 March 2012
Thomas Rosch, commissioner at the US Federal Trade Commission (FTC), says he plans to remain at the agency until a new commissioner is nominated and confirmed to take his place, even if that occurs after his current term expires in September.
Friday, 18 November 2011
US Federal Trade Commission (FTC) Chairman Jon Leibowitz says fighting against “pay-for-delay” settlements in pharmaceutical patent litigation will continue to be a priority for the commission should he be given a second term as chairman.
Wednesday, 26 October 2011
The number of so-called “pay-for-delay” patent settlements between branded and generic drug makers declined last year, but potentially anti-competitive settlements continue to be pervasive in the pharmaceutical industry, the US Federal Trade Commission says.
Wednesday, 12 October 2011
Featured In: October 2011 (Vol. 14 Iss. 9)
In late July, officials from the US Federal Trade Commission and the Department of Justice’s antitrust division travelled to Beijing to sign a memorandum of understanding with China’s antitrust agencies. The agreement provides that both countries may work together on antitrust cases and mergers that could have an impact on both economies. In the weeks after the agreement was signed, FTC Chairman Jon Leibowitz spoke to Ron Knox about its implications and the progress Chinese enforcers have made in the three years since the Anti-Monopoly Law (AML) came into force
Wednesday, 21 September 2011
Thomas Rosch, a commissioner at the US Federal Trade Commission, has asked a key US lawmaker to deny an attempt to attach pay-for-delay patent settlement reform to a larger, unrelated debt reduction bill.
Thursday, 26 May 2011
Featured In: May 2011 (Vol. 14 Iss. 5)
As US Federal Trade Commission Chairman Jon Leibowitz begins his second term at the agency, Rachel Bull asks him about the ever-present clearance battles with the DoJ, the commission’s ceaseless fight against pay-for-delay deals and whether a Google investigation is on the cards
Premium Article - Thursday, 23 September 2010
Jon Leibowitz, chairman of the US Federal Trade Commission, today called for greater competition in the privacy protection market. His remarks were delivered during a panel discussion on international competition enforcement at Fordham University's 37th annual conference on international antitrust law and policy. Emily Gray in New York
Premium Article - Wednesday, 22 September 2010
Jon Leibowitz, chairman of the US Federal Trade Commission, offered his assessment of the FTC’s performance over the past 12 months, at the Georgetown Law fourth annual Global Antitrust Enforcement Symposium. Emily Gray in Washington, DC
Premium Article - Friday, 30 October 2009
The chairman of the US Federal Trade Commission has praised lawmakers for including a repeal of an antitrust exemption for health insurers in the House of Representatives’ latest version of a health-care reform bill.
Premium Article - Friday, 16 October 2009
The Judiciary Committee of the US Senate yesterday approved a bill that would restrict “reverse payment settlements” between drug manufacturers, making most illegal under the country’s antitrust laws.
Premium Article - Tuesday, 13 October 2009
Featured In: October 2009 (Vol. 12 Iss. 9)
Over the past decade, officials from the two US antitrust authorities have searched for ways to end inter-agency fighting over the right to investigate potentially anti-competitive deals. So far, the search has yielded few results. Now, the country’s new antitrust regime says it has a plan. Can it work? Ron Knox investigates
Premium Article - Thursday, 08 October 2009
The head of the US Department of Justice’s antitrust division yesterday laid out the case for state and federal enforcers to bring resale price maintenance cases under the rule-of-reason standard mandated by the Supreme Court.
Premium Article - Thursday, 08 October 2009
A Virginia hospital network has agreed to sell off medical clinics it acquired last year after the US Federal Trade Commission said the acquisitions were anti-competitive and would increase customers’ costs.
Premium Article - Tuesday, 22 September 2009
Federal Trade Commission chairman Jon Leibowitz today announced that the US antitrust agencies will jointly revisit the country’s horizontal merger guidelines. Peter Scott in Washington, DC.
Back to top
